Cleveland Clinic Cardiovascular Med Chairman skeptical of Remdesivir’s
Post# of 148294
(Total Views: 778)
Posted On: 06/30/2020 8:53:44 AM
Cleveland Clinic Cardiovascular Med Chairman skeptical of Remdesivir’s price given it doesn't reduce mortality
“This is a high price for a drug that has not been shown to reduce mortality,” Dr. Steven Nissen of the Cleveland Clinic said in an email. “Given the serious nature of the pandemic, I would prefer that the government take over production and distribute the drug for free. It was developed using significant taxpayer funding.”
https://apnews.com/318e059fa2712c9624617ccd04960499
“This is a high price for a drug that has not been shown to reduce mortality,” Dr. Steven Nissen of the Cleveland Clinic said in an email. “Given the serious nature of the pandemic, I would prefer that the government take over production and distribute the drug for free. It was developed using significant taxpayer funding.”
https://apnews.com/318e059fa2712c9624617ccd04960499
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼